Khamenei Funeral Draws Thousands as Iran Stages Nationwide Week of Mourning 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak 
CDC Expands Ebola Screening Efforts at U.S. Entry Points Amid Congo and Uganda Outbreak 
Trump Marks America’s 250th Anniversary With National Mall Rally Amid Political Divide 
Taiwan Simulates Chinese Blockade and Invasion in Major Civil Defense Drill 
Russian Attacks Kill Six Across Ukraine as Kyiv Mourns Deadly Strike 
US Ambassador Prioritizes Cook Islands Critical Minerals, Warns of China’s Pacific Influence 
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
Russia Claims Capture of Kostiantynivka as Putin Pushes Donetsk Offensive 
Moody’s Says Peru’s President-Elect Keiko Fujimori Could Boost Investor Confidence 
EU Chip Industry Faces Growing Risks From China Export Controls and U.S. Technology Dependence: Report 
OpenAI Proposes 5% U.S. Government Stake Amid AI Policy Talks 
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
Venezuela Interim President Defends Earthquake Response as Death Toll Climbs 
Russia’s Deadly Kyiv Missile and Drone Attack Kills 27 as Zelensky Urges Faster Air Defense Support 
President Donald Trump had previously touted a two-drug combination as a potential treatment for the COVID-19. However, the US National Institutes of Health (NIH) warned that using the combination might expose coronavirus patients to some serious side effects.
President Donald Trump previously touted a drug combination as a possible treatment for the coronavirus in press briefings and social media posts. “Hydroxychloroquine and azithromycin, taken together, have a real chance to be one of the biggest game-changers in the history of medicine,” Trump tweeted in March, according to Financial Times. “The FDA has moved mountains - Thank You! Hopefully, they will BOTH (H works better with A, International Journal of Antimicrobial Agents)”
“What do you have to lose?” Trump said a couple of weeks ago. However, the President has been criticized by scientists “for promoting the drugs without conclusive scientific evidence that they work,” Forbes reported. After his comments, there were reported shortages of hydroxychloroquine for patients using the drug as a treatment for rheumatoid arthritis or lupus.
However, a panel from the NIH recommended against the use of hydroxychloroquine and azithromycin because they are “associated with QTc prolongation in patients with COVID-19.” According to Forbes, “QTc prolongation is associated with abnormalities in heart rhythm or sudden cardiac death.”
The experts also warned that the drug combination might result in possible toxicities, according to FT, The toxicities could result in further serious side effects, which include poisoning.
The NIH report was done by a panel of health experts that included members of the team led by Anthony Fauci. The report was published on NIH’s website on Tuesday.
The study involved 368 COVID-19 patients at hospitals run by the Veterans Health Administration. Researchers found out that there were more deaths among patients taking a combination of hydroxychloroquine and azithromycin compared to patients who were not taking the drug combo.
At a recent news conference, Trump promised to look into the NIH report but he also clarified that he is not aware of the study. “There have been some very good reports and perhaps this one’s not a good report, but we’ll be looking at it,” the President said.
